Elevate Campuses Ltd vs Omkar Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 22, 2026

Key Highlights

The Latest Trading Price of Elevate Campuses Ltd is ₹ 299.7 as of 22 Oct 15:30 . The P/E Ratio of Elevate Campuses Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Omkar Pharmachem Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Elevate Campuses Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Omkar Pharmachem Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Revenue of Elevate Campuses Ltd is ₹ 284.66 crore as of Jun '25 .The Revenue of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Elevate Campuses Ltd is ₹ 245.18 crore as of Jun '25 .The EBITDA of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Elevate Campuses Ltd is ₹ 118.74 crore as of Jun '25 .The Net Profit of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Elevate Campuses Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Omkar Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Elevate Campuses Ltd

Elevate Campuses Limited was originally incorporated as 'Woodstock Ambience Private Limited' on April 8, 2005, as a private limited company at Bengaluru, Karnataka, India.
The name of the Company was changed to 'Good Host Spaces Private Limited', dated January 9, 2018.
Upon conversion of Company into a public limited company, the name of Company was changed to 'Good Host Spaces Limited', and a fresh certificate of incorporation dated August 20, 2025, was issued by the RoC. Thereafter, the name was subsequently changed to 'Elevate Campuses Limited', and a fresh certificate of incorporation was issued by the Central Processing Centre on September 8, 2025. The Company own, operate and manage on-campus student accommodation across higher education institutions (HEIs) and owning K-12 Assets in India.

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated on March 31, 1995.
The Company has not done any commercial activity during the year.
At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product in 2017-18. The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
Currently, Company is engaged in business of providing support services related activities.

FAQs for the comparison of null and Omkar Pharmachem Ltd

Which company has a larger market capitalization, Elevate Campuses Ltd or Omkar Pharmachem Ltd?

Market cap of Elevate Campuses Ltd is 5,050 Cr while Market cap of Omkar Pharmachem Ltd is 7 Cr

What are the key factors driving the stock performance of Elevate Campuses Ltd and Omkar Pharmachem Ltd?

The stock performance of Elevate Campuses Ltd and Omkar Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Elevate Campuses Ltd and Omkar Pharmachem Ltd?

As of October 22, 2026, the Elevate Campuses Ltd stock price is INR ₹299.7. On the other hand, Omkar Pharmachem Ltd stock price is INR ₹7.59.

How do dividend payouts of Elevate Campuses Ltd and Omkar Pharmachem Ltd compare?

To compare the dividend payouts of Elevate Campuses Ltd and Omkar Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.